〉The Council Chairman
〉Daiming Fan
〉Vice Presidents
〉Qimin Zhan
〉Jie He
〉Xiaomao Guo
〉Ruihua Xu
〉Haozhe Piao
〉Yongzhong Wu
〉Wei Lu
〉Ying Wang
〉Jiangong Zhang
〉Xiangdong Cheng
〉Ziyu Li
〉Hanping Shi
〉The General Secretary
〉Yong Zhao
|
|
|
| |
Vice Presidents
Shujun Cheng |
 |
|
| Dr. Shujun Cheng, Professor, Dept. of Etiology and Chemical Carcinogenesis, Cancer Institute (Hospital), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Dr. Shujun Cheng is the Professor of Cancer Institute (Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College. He is the Chief Scientist of China State Key Basic Research Project "Fundamental Investigation of Human Carcinogenesis and Cancer Therapy and Prevention". He is also the President of Chinese Environmental Mutagen Society. Prof. Cheng developed an approach to studying human lung cancer-related proteins in human blood. He established four immortalized Chinese bronchial epithelial cell lines, which were used for the studies of human lung carcinogenesis. He has established short-term tests for the detection of environmental carcinogens and anticarcinogens. He found that tea polyphenon showed a significant inhibitory effect against human genital condylomas and inflammatory hyperplasia. Based on the studies of tea polyphenon, Prof. Cheng and his collaborators had received international patents “Composition for treating condyloma acuminate” in 1998. Tea polyphenon had been approved by US FDA as a prescription drug for the treatment of human genital warts in 2006. He was elected as the Member of Chinese Academy of Engineering in 1999.
|
|
